ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 591

The Fat Spondyloarthritis Spine Score (FASSS) Independently Predicts Radiographic Progression in Patients with Ankylosing Spondylitis

Susanne Juhl Pedersen1, Stephanie Wichuk2, Praveena Chiowchanwisawakit3, Zheng Zhao4, Robert GW Lambert5 and Walter P. Maksymowych6, 1Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3Mahidol University, Bangkok, Thailand, 4PLA General Hospital, Beijing, China, 5Radiology, University of Alberta, Edmonton, AB, Canada, 6Medicine/Rheumatic Dis Unit, University of Alberta, Edmonton, AB, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), magnetic resonance imaging (MRI) and prognostic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

The Fat Spondyloarthritis Spine Score (FASSS) independently predicts radiographic progression in patients with ankylosing spondylitis.  

Background/Purpose Vertebral corner fat lesions have been shown to be associated with later development of new syndesmophytes in the same vertebral corners1,2. The aim of this study was to investigate the association between fat lesions and radiographic progression at the patient level using the novel Fat Spondyloarthritis Spine Score (FASSS)3. This could lead to an important target for therapeutic intervention..

Methods 157 patients with AS (N (%) male sex: 121 (77%); receiving TNFα inhibitor: 93 (59%); mean (SD) age: 39.4 (11.7); symptom duration: 15.9 (10.2)) had MRIs and X-rays performed with a mean (SD) follow-up of 2.3 (0.7) years and 2.2 (0.68) years. Status and change in fat lesions were assessed with FASSS and radiographic progression with the modified Stoke AS Spine Score (mSASSS). Two readers independently read MRIs scans and radiographs, and an adjudicator re-assessed discrepant cases according to pre-specified rules. Multivariate stepwise regression analysis included variables significant in univariate analyses (age, sex, symptom duration, baseline CRP, baseline mSASSS) and treatment.

Results When mSASSS progression was dichotomized (mSASSS progression yes/no), baseline FASSS scores were significantly higher in the progression group as compared to the non-progression group (20.0 (21.6) vs. 12.9 (22.5), p<0.001). When a pre-specified FASSS cut-off of 5 was used, which has been suggested as a definition of a "positive spine MRI"4, higher rates of radiographic progression were seen in patients with score ≥5 vs. <5 (1.19 (1.52) vs 0.34 (0.72), p<0.001). In the regression analyses baseline FASSS score was the only independent predictor of radiographic progression (β=0.008, p=0.0004). Figure 1 shows patients with a baseline FASSS scores ≥5 had a higher cumulative probability of radiographic progression.

 

Conclusion A positive spine MRI for fat assessed with FASSS, and the degree of spinal fat are significantly associated with radiographic progression in patients with AS.

References

1Baraliakos X et al. Ann Rheum Dis. 2013 (online)

2Chiowchanwisawakit P et al. Arthritis Rheum. 2011;63:2215-25

3Pedersen SJ et al. Arthritis Res Ther. 2014:16:R100;

4Bennett AN et al. Ann Rheum Dis 2010;69:891-4.


Disclosure:

S. J. Pedersen,
None;

S. Wichuk,
None;

P. Chiowchanwisawakit,
None;

Z. Zhao,
None;

R. G. Lambert,
None;

W. P. Maksymowych,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-fat-spondyloarthritis-spine-score-fasss-independently-predicts-radiographic-progression-in-patients-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology